Focus on Intermediate-Risk Acute Pulmonary Embolism. Is the Combination of Biomarkers the Solution?

Arq Bras Cardiol. 2024 Apr 26;121(2):e20240075. doi: 10.36660/abc.20240075. eCollection 2024.

[Article in Portuguese, English]

Author

Carlos Henrique Miranda¹

Affiliation

¹ Divisão de Medicina de Emergência, Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP - Brasil.

No abstract available

Publication types

Editorial

MeSH terms

Acute Disease
Biomarkers* / analysis
Biomarkers* / blood
Humans
Pulmonary Embolism* / diagnostic imaging
Risk Assessment
Risk Factors

Substances

Biomarkers